A Clinical Trial for Evaluation of Adequate Dose and Safety of DW-3102 in Hypercholesterolemia Patients
Clinical trial NCT02368613 · UNKNOWN
Trial details
- NCT number
- NCT02368613
- Sponsor
- Daewon Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Primary completion
- 2017-10-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.